Imunon Croissance future
Future contrôle des critères 0/6
Imunon's earnings are forecast to decline at 19.6% per annum while its annual revenue is expected to grow at 82.9% per year. EPS is expected to grow by 36% per annum.
Informations clés
-19.6%
Taux de croissance des bénéfices
36.0%
Taux de croissance du BPA
Biotechs croissance des bénéfices | 37.3% |
Taux de croissance des recettes | 82.9% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 31 Oct 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | N/A | -35 | -45 | -46 | 4 |
12/31/2025 | N/A | -27 | -37 | -34 | 4 |
12/31/2024 | N/A | -22 | -29 | -29 | 4 |
6/30/2024 | N/A | -18 | -19 | -19 | N/A |
3/31/2024 | N/A | -19 | -21 | -21 | N/A |
12/31/2023 | N/A | -20 | -19 | -19 | N/A |
9/30/2023 | 0 | -28 | -21 | -20 | N/A |
6/30/2023 | 0 | -31 | -21 | -20 | N/A |
3/31/2023 | 0 | -31 | -19 | -19 | N/A |
12/31/2022 | 1 | -36 | -23 | -23 | N/A |
9/30/2022 | 1 | -27 | -23 | -23 | N/A |
6/30/2022 | 1 | -26 | -23 | -22 | N/A |
3/31/2022 | 1 | -26 | -20 | -19 | N/A |
12/31/2021 | 1 | -21 | -17 | -16 | N/A |
9/30/2021 | 1 | -20 | -15 | -15 | N/A |
6/30/2021 | 1 | -22 | -15 | -15 | N/A |
3/31/2021 | 1 | -22 | -16 | -15 | N/A |
12/31/2020 | 1 | -21 | -16 | -16 | N/A |
9/30/2020 | 1 | -22 | -18 | -18 | N/A |
6/30/2020 | 1 | -19 | -18 | -18 | N/A |
3/31/2020 | 1 | -20 | -20 | -20 | N/A |
12/31/2019 | 1 | -17 | -21 | -20 | N/A |
9/30/2019 | 1 | -8 | -9 | -9 | N/A |
6/30/2019 | 1 | -7 | -9 | -8 | N/A |
3/31/2019 | 1 | -10 | -8 | -8 | N/A |
12/31/2018 | 1 | -12 | -7 | -7 | N/A |
9/30/2018 | 1 | -22 | -17 | -17 | N/A |
6/30/2018 | 1 | -23 | -18 | -18 | N/A |
3/31/2018 | 1 | -20 | N/A | -18 | N/A |
12/31/2017 | 1 | -21 | N/A | -17 | N/A |
9/30/2017 | 1 | -21 | N/A | -17 | N/A |
6/30/2017 | 1 | -22 | N/A | -17 | N/A |
3/31/2017 | 1 | -21 | N/A | -17 | N/A |
12/31/2016 | 1 | -22 | N/A | -18 | N/A |
9/30/2016 | 1 | -22 | N/A | -18 | N/A |
6/30/2016 | 1 | -20 | N/A | -18 | N/A |
3/31/2016 | 1 | -21 | N/A | -20 | N/A |
12/31/2015 | 1 | -22 | N/A | -21 | N/A |
9/30/2015 | 1 | -23 | N/A | -23 | N/A |
6/30/2015 | 1 | -26 | N/A | -24 | N/A |
3/31/2015 | 1 | -27 | N/A | -22 | N/A |
12/31/2014 | 1 | -25 | N/A | -21 | N/A |
9/30/2014 | 1 | -23 | N/A | -18 | N/A |
6/30/2014 | 1 | -20 | N/A | -15 | N/A |
3/31/2014 | 1 | -13 | N/A | -16 | N/A |
12/31/2013 | 1 | -13 | N/A | -10 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 0HUZ is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: 0HUZ is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: 0HUZ is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: 0HUZ is forecast to have no revenue next year.
Croissance élevée des revenus: 0HUZ is forecast to have no revenue next year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if 0HUZ's Return on Equity is forecast to be high in 3 years time